Association of loss of heterozygosity and PTEN gene abnormalities with paraclinical, clinical modalities and survival time of glioma patients in Malaysia

• Published in: Asian Journal of Surgery
• Main Author: Abdullah J.M.; Farizan A.; Asmarina K.; Zainuddin N.; Ghazali M.M.; Jaafar H.; Isa M.N.; Naing N.N.
• Format: Article
• Language: English
• Published: Elsevier (Singapore) Pte Ltd 2006
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750708233&doi=10.1016%2fS1015-9584%2809%2960102-0&partnerID=40&md5=a1632106ea27b4a4c43062fde18f7cd1

BACKGROUND: The pattern of allelic loss of heterozygosity (LOH) and PTEN mutations appear to be associated with the progression of gliomas leading to a decrement in the survival rate of patients. This present study was carried out to determine the LOH and PTEN mutational status in glioma patients and its association with patients' survival. METHODS: Thirty-seven Malaysian glioma patients of the Malay race were subject to PTEN mutational analysis and the presence of LOH using the cold single-strand conformation polymorphism method, and their clinical and paraclinical response were correlated. RESULTS: Among analysed glioma patients, seven (21.6%) cases with PTEN mutations were detected and 12 (32.4%) of 37 patients showed presence of LOH. Univariate analysis showed that tumour grade, vascularization, PTEN mutation, LOH and combination of both PTEN mutation and LOH were significantly associated with glioma patients' survival. Multivariate analysis revealed that no factors contributed to survival time. CONCLUSION: The results show that PTEN mutation and LOH are quite frequent in Malaysian glioma patients. However, they have no impact on the survival outcome of patients. © 2006 Elsevier. All rights reserved.